Ballentine Partners’s ProQR Therapeutics PRQR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-23,035
Closed -$61K 981
2024
Q4
$61K Buy
+23,035
New +$61K ﹤0.01% 865